VeriMomHamilelikte hydrolyzed wintergreen extract kullanmaktan kaçınmalı mıyım? | VeriMom
Regulatory and scientific reviews treat methyl salicylate (the main constituent of wintergreen) as a substance of reproductive concern (SCCS/ECHA activity and ECHA/C&L references indicate a Repr.2/H361-level concern), so hazard is scored as suspected (h=2). Salicylates are metabolized to salicylate which is known to cross the placenta (mechanism demonstrated), so m=2. Dermal use of methyl salicylate produces measurable systemic exposure (used clinically in topical analgesics), so topical exposure is moderate (e=2). Sources: SCCS scientific advice on children’s exposure to methyl salicylate; ECHA/C&L and registration pages; CIR safety assessment of salicylates.
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- hydrolyzed wintergreen extract hamilelikte güvenli mi?
- Regulatory and scientific reviews treat methyl salicylate (the main constituent of wintergreen) as a substance of reproductive concern (SCCS/ECHA activity and ECHA/C&L references indicate a Repr.2/H361-level concern), so hazard is scored as suspected (h=2). Salicylates are metabolized to salicylate which is known to cross the placenta (mechanism demonstrated), so m=2. Dermal use of methyl salicylate produces measurable systemic exposure (used clinically in topical analgesics), so topical exposure is moderate (e=2). Sources: SCCS scientific advice on children’s exposure to methyl salicylate; ECHA/C&L and registration pages; CIR safety assessment of salicylates.
- hydrolyzed wintergreen extract emzirirken güvenli mi?
- Same intrinsic hazard (methyl salicylate → salicylate) so h=2. Mechanistic evidence of salicylate systemic distribution and transfer supports m=2. Dermal/topical products containing methyl salicylate can lead to measurable systemic levels; breastmilk transfer of salicylates is plausible based on known salicylate pharmacokinetics, so exposure for a breastfeeding parent is moderate (e=2). No infant-specific milk-transfer quantitative studies for methyl salicylate were identified in the searched sources.
- hydrolyzed wintergreen extract bebek cildi için güvenli mi?
- Hazard and mechanism follow the parent compound (methyl salicylate) → h=2, m=2. Because infants (0–3 yr) have higher skin permeability and surface-area-to-weight, and regulators (SCCS) have issued specific tighter limits for methyl salicylate in products for 0–3 yr, exposure for baby skin from topical products is increased by +1 (adult e=2 → infant e=3). SCCS specifically reviewed children’s exposure and set much lower concentration limits for 0–3 year products, indicating elevated concern for this age group.
- VeriMom hydrolyzed wintergreen extract nasıl puanlıyor?
- VeriMom hydrolyzed wintergreen extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 33/100 (yüksek risk) olarak puanlar.
- Hamilelikte hydrolyzed wintergreen extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.